⚠ Intuitive Now Owns the Underused MachinesModerate threat

Intuitive Surgical (ISRG) — threat to the moat

$5.3 billion of property and equipment, a growing part of it systems sitting in somebody else's hospital.

Every usage-based lease is an asset Intuitive built, paid for and still owns, generating revenue only when somebody operates.

Property, plant and equipment, net ($M)$4,646.6MEnd 2024$5,342.4MEnd 2025496 usage-based systems placed in 2025 into a market growing 18%; 2026 guidance is 13.5% to 15.5%.
Intuitive states there is no guarantee it recovers the cost of a leased system if utilisation differs from expectations. It now owns 1,810 of them.

The exposure is stated by the company: "because of the variability in revenue recognized for usage-based lease arrangements, including our customers' ability to exit or cancel those arrangements prior to the end of the lease term, there is no guarantee that we will recuperate the cost of the leased system, which, in turn, could adversely impact our gross profit margins if utilization of those systems are different than our expectations"1.

The balance sheet shows the scale of the commitment: property, plant and equipment net rose from $4,646.6 million to $5,342.4 million during 20252, on a company whose manufacturing footprint did not change dramatically. A growing share of that is leased systems.

The timing question is whether the underwriting assumed a procedure-growth rate that is now being revised. Intuitive placed 496 usage-based systems in 2025 into a market growing 18%; it guided 2026 procedure growth to 13.5-15.5%3 and delivered 12% in the United States in the June quarter4.

There is a partial offset in the structure. Usage-based leases are offered to "qualified customers that have committed da Vinci programs"5 — that is, to hospitals with a track record, not to speculative starters. That selection is the real credit control, and it has worked so far.

Gross margin is the tell. Intuitive says that "lease transactions generate similar gross profit margins as our sale transactions"; a widening gap between reported gross margin and the guided range, unexplained by tariffs, would be the first evidence that leased systems are not earning out.

References
  1. ReportedThe exposure is stated by the company: "because of the variability in revenue recognized for usage-based lease arrangements, including our customers' ability to exit or cancel those arrangements prior to the end of the lease term, there is...
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
  2. ReportedThe balance sheet shows the scale of the commitment: property, plant and equipment net rose from $4,646.6 million to $5,342.4 million during 2025, on a company whose manufacturing footprint did not change dramatically.
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - consolidated financial statements and notes (balance sheet, cash and investments, property and equipment, lease arrangements, revenue disaggregation by geography, accounts receivable, share-based compensation and share counts) — FY2025 · publ. February 3, 2026 · source ↗
  3. ReportedIntuitive placed 496 usage-based systems in 2025 into a market growing 18%; it guided 2026 procedure growth to 13.5-15.5% and delivered 12% in the United States in the June quarter.
    Intuitive Surgical second-quarter 2026 results release (Form 8-K exhibit 99.1) - revenue $2,892.3M up 19%, operating income $971.9M, GAAP diluted earnings of $2.29 against non-GAAP $2.80, recurring revenue 85% of the total, and the quarter's procedure and placement figures — Q2 2026 · publ. July 16, 2026 · source ↗
  4. ReportedIntuitive placed 496 usage-based systems in 2025 into a market growing 18%; it guided 2026 procedure growth to 13.5-15.5% and delivered 12% in the United States in the June quarter.
    Intuitive Surgical second-quarter 2026 results release (Form 8-K exhibit 99.1) - revenue $2,892.3M up 19%, operating income $971.9M, GAAP diluted earnings of $2.29 against non-GAAP $2.80, recurring revenue 85% of the total, and the quarter's procedure and placement figures — Q2 2026 · publ. July 16, 2026 · source ↗
  5. ReportedUsage-based leases are offered to "qualified customers that have committed da Vinci programs" — that is, to hospitals with a track record, not to speculative starters.
    Intuitive Surgical Form 10-K, fiscal year ended December 31, 2025 - Item 7 MD&A, results of operations (instruments and accessories $6,018.9M, systems $2,473.7M, service $1,572.1M, recurring revenue $8,465.3M, gross margin 66.0%, operating income $2,945.5M, average selling price, lease revenue recognition, and the discussion of procedure categories) — FY2025 · publ. February 3, 2026 · source ↗
Sources
Generated September 23, 2026